Cresset and Optibrium Announce Technology Collaboration

Technology exchange combines unique methods for design of novel, high quality compounds in drug discovery

06-Jan-2012 - United Kingdom

Cresset and Optibrium announced an agreement to collaborate on the development of next-generation platforms. The companies will work together, combining unique approaches to help drug discovery projects quickly identify novel, potent compounds with a high chance of success downstream.

The collaboration will involve a two-way exchange of technologies: Optibrium’s ADME models, currently provided as a plug-in module for its StarDrop™ software platform, will be made available to users of Cresset’s desktop applications. Similarly, Cresset’s FieldAlignTM software, which helps chemists understand the three-dimensional structure-activity-relationship of their chemistry in order to design active compounds, will be made available as an optional plug-in module for StarDrop, which helps project teams to confidently target compounds with a good balance of properties for their therapeutic objectives.
 

Other news from the department business & finance

These products might interest you

Limsophy

Limsophy by AAC Infotray

Optimise your laboratory processes with Limsophy LIMS

Seamless integration and process optimisation in laboratory data management

laboratory information management systems
ERP-Software GUS-OS Suite

ERP-Software GUS-OS Suite by GUS

Holistic ERP solution for companies in the process industry

Integrate all departments for seamless collaboration

software
Loading...

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance